[
  {
    "ts": "2025-06-23T13:22:00+00:00",
    "headline": "J&J Adds More Than $15B in Six Months: How to Play JNJ Stock?",
    "summary": "JNJ stock added $15B in market value in six months as new drug launches offset MedTech and Stelara headwinds.",
    "url": "https://finance.yahoo.com/news/j-j-adds-more-15b-132200263.html",
    "source": "Zacks",
    "provider": "yfinance",
    "raw": {
      "id": "63b81238-7ed7-3a9c-a103-69bf80948b59",
      "content": {
        "id": "63b81238-7ed7-3a9c-a103-69bf80948b59",
        "contentType": "STORY",
        "title": "J&J Adds More Than $15B in Six Months: How to Play JNJ Stock?",
        "description": "",
        "summary": "JNJ stock added $15B in market value in six months as new drug launches offset MedTech and Stelara headwinds.",
        "pubDate": "2025-06-23T13:22:00Z",
        "displayTime": "2025-06-23T13:22:00Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/zacks.com/74bab520128f201c7e6cc3f67385e761",
          "originalWidth": 635,
          "originalHeight": 400,
          "caption": "",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/tugIemz.T.iquqxVIoxpHw--~B/aD00MDA7dz02MzU7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/zacks.com/74bab520128f201c7e6cc3f67385e761.cf.webp",
              "width": 635,
              "height": 400,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/SHyaOdZAc4DXCya2O4.DtQ--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/zacks.com/74bab520128f201c7e6cc3f67385e761.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Zacks",
          "url": "http://www.zacks.com/"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/j-j-adds-more-15b-132200263.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/j-j-adds-more-15b-132200263.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "KVUE"
            },
            {
              "symbol": "TEVA"
            },
            {
              "symbol": "TEVJF"
            },
            {
              "symbol": "JNJ"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2025-06-23T11:20:35+00:00",
    "headline": "When Should You Buy Kenvue Inc. (NYSE:KVUE)?",
    "summary": "Today we're going to take a look at the well-established Kenvue Inc. ( NYSE:KVUE ). The company's stock received a lot...",
    "url": "https://finance.yahoo.com/news/buy-kenvue-inc-nyse-kvue-112035664.html",
    "source": "Simply Wall St.",
    "provider": "yfinance",
    "raw": {
      "id": "bdc4ea2b-10fe-3ad8-8747-43c5ee179325",
      "content": {
        "id": "bdc4ea2b-10fe-3ad8-8747-43c5ee179325",
        "contentType": "STORY",
        "title": "When Should You Buy Kenvue Inc. (NYSE:KVUE)?",
        "description": "",
        "summary": "Today we're going to take a look at the well-established Kenvue Inc. ( NYSE:KVUE ). The company's stock received a lot...",
        "pubDate": "2025-06-23T11:20:35Z",
        "displayTime": "2025-06-23T11:20:35Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/simply_wall_st__316/8045a103f8959173903f7a11497803b2",
          "originalWidth": 1194,
          "originalHeight": 432,
          "caption": "",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/f4GJp67mVoQwpJ.a887rCA--~B/aD00MzI7dz0xMTk0O2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/simply_wall_st__316/8045a103f8959173903f7a11497803b2.cf.webp",
              "width": 1194,
              "height": 432,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/aEecC8iCl44YYumVOgbkQA--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/simply_wall_st__316/8045a103f8959173903f7a11497803b2.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Simply Wall St.",
          "url": "https://simplywall.st/"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/buy-kenvue-inc-nyse-kvue-112035664.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/buy-kenvue-inc-nyse-kvue-112035664.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "KVUE"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2025-06-23T05:01:00+00:00",
    "headline": "KVUE- A Beauty Care Turnaround Play Mulling Key Moves",
    "summary": "As part of its broader restructuring efforts, Kenvue Inc. (KVUE) is considering the sale of some of its skin health and beauty brands. KVUE is currently rated a “Buy” in the portfolio, highlights Clif Droke, editor of Cabot Turnaround Letter.",
    "url": "https://finance.yahoo.com/news/kvue-beauty-care-turnaround-play-050100039.html",
    "source": "MoneyShow",
    "provider": "yfinance",
    "raw": {
      "id": "466605f3-4eaa-35e6-bd5c-4c6a40d3f7c6",
      "content": {
        "id": "466605f3-4eaa-35e6-bd5c-4c6a40d3f7c6",
        "contentType": "STORY",
        "title": "KVUE- A Beauty Care Turnaround Play Mulling Key Moves",
        "description": "",
        "summary": "As part of its broader restructuring efforts, Kenvue Inc. (KVUE) is considering the sale of some of its skin health and beauty brands. KVUE is currently rated a “Buy” in the portfolio, highlights Clif Droke, editor of Cabot Turnaround Letter.",
        "pubDate": "2025-06-23T05:01:00Z",
        "displayTime": "2025-06-23T05:01:00Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": null,
        "provider": {
          "displayName": "MoneyShow",
          "url": "https://www.moneyshow.com/"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/kvue-beauty-care-turnaround-play-050100039.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/kvue-beauty-care-turnaround-play-050100039.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "KVUE"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  }
]